Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
51 hedge funds and large institutions have $25M invested in Ampio Pharmaceuticals Inc. in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 17 closing their positions.
75% more call options, than puts
Call options by funds: $813K | Put options by funds: $464K
6% more capital invested
Capital invested by funds: $23.7M → $25M (+$1.32M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
20% less funds holding
Funds holding: 64 → 51 (-13)
76% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CK
Carnick & Kubik
Colorado Springs,
Colorado
|
+$409K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$164K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$161K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$61.1K |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$42.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$868K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$664K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$325K |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$255K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$207K |
AMPE Hedge Fund Activity: Q3 2015 in Review
51 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2015, worth a combined $25M — up 5.6% from $23.7M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of AMPE and 4 opened new positions — a net loss of 13 holders — while 13 trimmed existing stakes and 11 added.
The largest buyer was Carnick & Kubik, opening a new position worth an estimated $409K. The largest seller was Northern Trust, cutting an estimated $868K.
- 51 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2015, down from 64 in Q2 2015.
- Funds reported $25M of Ampio Pharmaceuticals Inc. stock for Q3 2015, up 5.6% quarter-over-quarter.
- 4 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2015 and 17 closed out, a net change of -13 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q3 2015 was Carnick & Kubik, an estimated $409K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2015 was Northern Trust, an estimated $868K sold.
Based on aggregated 13F filings for Q3 2015.